Presentation slides and video from the 2024 Advances in Cancer Immunotherapy™ (ACI) Series: A Focus on Cellular Therapies, T cell Engagers and TIL Therapies were presented virtually on April 16, 2024.
Program Organizers
Target Audience
The Advances in Cancer Immunotherapy™ (ACI) programs aim to reach practicing clinical oncologists, nurses, nurse practitioners, advanced practitioners, pharmacists, emergency physicians, and other allied health professionals who wish to learn the basic principles of cancer immunotherapy and the most up-to-date clinical data for these treatments, in a multitude of disease states/therapeutic areas, in order to inform and integrate into their own clinical practice. In-training oncologists and hospital administrators will also find the program beneficial.
Program Learning Objectives
You can view the program agenda here.
Please note on-demand recordings are not available for continuing education credits.
Meeting: 2024 Advances in Cancer Immunotherapy™ Series: A Focus on Cellular Therapies, T cell Engagers and TIL Therapies; Date: April 16, 202400:39:46
Meeting: 2024 Advances in Cancer Immunotherapy™ Series: A Focus on Cellular Therapies, T cell Engagers and TIL Therapies; Presenter: Marian Dam, DNP, APRN, CDCES; Date: April 16, 202400:16:52
Meeting: 2024 Advances in Cancer Immunotherapy™ Series: A Focus on Cellular Therapies, T cell Engagers and TIL Therapies; Presenter: Bonnie Yates, MSN, CPNP-AC; Date: April 16, 202400:18:56
Meeting: 2024 Advances in Cancer Immunotherapy™ Series: A Focus on Cellular Therapies, T cell Engagers and TIL Therapies; Presenter: Rajshekhar Chakraborty, MD; Date: April 16, 202400:32:19
Meeting: 2024 Advances in Cancer Immunotherapy™ Series: A Focus on Cellular Therapies, T cell Engagers and TIL Therapies; Presenter: Ecaterina Dumbrava, MD; Date: April 16, 202400:30:47
Meeting: 2024 Advances in Cancer Immunotherapy™ Series: A Focus on Cellular Therapies, T cell Engagers and TIL Therapies; Presenter: Amod Sarnaik, MD; Date: April 16, 202400:26:58
Meeting: 2024 Advances in Cancer Immunotherapy™ Series: A Focus on Cellular Therapies, T cell Engagers and TIL Therapies; Presenter: Marco Davila, MD, PhD; Date: April 16, 202400:20:01
Meeting: 2024 Advances in Cancer Immunotherapy™ Series: A Focus on Cellular Therapies, T cell Engagers and TIL Therapies; Presenter: Michael Jain, MD, PhD; Date: April 16, 202400:20:58
Meeting: 2024 Advances in Cancer Immunotherapy™ Series: A Focus on Cellular Therapies, T cell Engagers and TIL Therapies; Presenter: Christian Capitini, MD; Date: April 16, 202400:05:48